Actively Recruiting
PDA for Kidneys Study
Led by University of Wisconsin, Madison · Updated on 2026-02-03
45
Participants Needed
1
Research Sites
123 weeks
Total Duration
On this page
Sponsors
U
University of Wisconsin, Madison
Lead Sponsor
T
The Gerber Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.
CONDITIONS
Official Title
PDA for Kidneys Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Delivered at <32 weeks' gestation
- 72 hours of age or less
- Inpatient at Meriter Hospital, Inc. NICU
- At least one parent/guardian able to provide permission in English or Spanish
You will not qualify if you...
- Major congenital anomalies of kidney
- Physician decides not to place NIRS sensors due to clinical concerns
- Significant likelihood neonate would not survive first 3 days of life
- Birth parent younger than 18 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Meriter Hospital, Inc.
Madison, Wisconsin, United States, 53715
Actively Recruiting
Research Team
P
Paige Condit, MD
CONTACT
M
Meg Baker
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here